TransMedics Reports Fourth Quarter and Full Year 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. WCN
6. SPOT
7. FIX
8. BE
9. BMY
10. PNFP

Go back to TransMedics Reports Fourth Quarter and Full Year 2021 Financial Results

TransMedics Group (TMDX) PT Lowered to $28 at Cowen

February 24, 2022 6:56 AM EST

Cowen analyst Joshua Jennings lowered the price target on TransMedics Group (NASDAQ: TMDX) to $28.00 (from $29.00) while maintaining an Outperform rating.

The analyst commented, "TMDX reported 4Q sales of $9.7M, up 27%, vs the $7.5M consensus. It introduced 2022 sales guidance of $49M-$55M, reflecting... More

TransMedics Group (TMDX) Misses Q4 EPS by 4c

February 23, 2022 4:28 PM EST

TransMedics Group (NASDAQ: TMDX) reported Q4 EPS of ($0.46), $0.04 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $7.52 million.

For earnings history and earnings-related data on TransMedics Group (TMDX) click here.

... More